These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9481468)

  • 1. Newer, safer nonsteroidal anti-inflammatory drugs. Rational NSAID selection for arthritis.
    Bensen W; Zizzo A
    Can Fam Physician; 1998 Jan; 44():101-2, 105-7. PubMed ID: 9481468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis.
    Simon LS; Zhao SZ; Arguelles LM; Lefkowith JB; Dedhiya SD; Fort JG; Johnson KE
    Clin Ther; 1998; 20(6):1218-35; discussion 1192-3. PubMed ID: 9916614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database.
    Schnitzer TJ; Kong SX; Mavros PP; Straus WL; Watson DJ
    Clin Ther; 2001 Dec; 23(12):1984-98. PubMed ID: 11813933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
    Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
    Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the gastrointestinal safety of NSAIDs: the development of misoprostol--from hypothesis to clinical practice.
    Silverstein FE
    Dig Dis Sci; 1998 Mar; 43(3):447-58. PubMed ID: 9539636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nabumetone: a new NSAID for rheumatoid arthritis and osteoarthritis.
    Roth SH
    Orthop Rev; 1992 Feb; 21(2):223-7. PubMed ID: 1538889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of low-dose misoprostol and naproxen vs. nabumetone to prevent recurrent upper gastrointestinal haemorrhage in users of non-steroidal anti-inflammatory drugs.
    Chan FK; Sung JJ; Ching JY; Wu JC; Lee YT; Leung WK; Hui Y; Chan LY; Lai AC; Chung SC
    Aliment Pharmacol Ther; 2001 Jan; 15(1):19-24. PubMed ID: 11136274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity.
    Kim JH; Park SH; Cho CS; Lee ST; Yoo WH; Kim SK; Kang YM; Rew JS; Park YW; Lee SK; Lee YC; Park W; Lee DH
    Gut Liver; 2014 Jul; 8(4):371-9. PubMed ID: 25071901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials.
    Leandro G; Pilotto A; Franceschi M; Bertin T; Lichino E; Di Mario F
    Dig Dis Sci; 2001 Sep; 46(9):1924-36. PubMed ID: 11575445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis. A review and suggestions.
    Greene JM; Winickoff RN
    Arch Intern Med; 1992 Oct; 152(10):1995-2002. PubMed ID: 1417372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nonsteroidal anti-inflammatory drugs and misoprostol on gastroduodenal epithelial proliferation in arthritis.
    Levi S; Goodlad RA; Lee CY; Walport MJ; Wright NA; Hodgson HJ
    Gastroenterology; 1992 May; 102(5):1605-11. PubMed ID: 1568570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal toxicity of newer NSAIDs.
    Lanza FL
    Am J Gastroenterol; 1993 Sep; 88(9):1318-23. PubMed ID: 8362824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatories and gastroduodenal damage: therapeutic options.
    Agrawal NM
    Eur J Rheumatol Inflamm; 1993; 13(1):17-24. PubMed ID: 7821335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
    Hawkey CJ; Karrasch JA; Szczepañski L; Walker DG; Barkun A; Swannell AJ; Yeomans ND
    N Engl J Med; 1998 Mar; 338(11):727-34. PubMed ID: 9494149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitigating GI risks associated with the use of NSAIDs.
    Momeni M; Katz JD
    Pain Med; 2013 Dec; 14 Suppl 1():S18-22. PubMed ID: 24373106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs].
    László A
    Orv Hetil; 2002 Jul; 143(27):1643-8. PubMed ID: 12180001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.